Advertisement

Picture Demy-Colton BioFuture 2024 NYC Game Changers 650x100px
Organisation › Details

Tempus Labs Inc.

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care. In parallel, Tempus facilitates discovery, development and delivery of optimized therapeutic options for patients through distinctive solution sets. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. *

 

Period Start 2015-01-01 established
Products Industry personalised medicine / precision medicine
  Industry 2 bioinformatics (biological software and databases)
Person Person Lefkofsky, Eric (Tempus Labs 202003 CEO + Founder)
     
Region Region Chicago, IL
  Country United States (USA)
  Street 600 West Chicago Avenue
Suite 510
  City 60654 Chicago, IL
    Address record changed: 2024-01-05
     
Basic data Employees F: 1,001 to 5,000 (2020-12-10)
     
    * Document for »About Section«: Tempus Labs, Inc.. (3/13/20). "Press Release: Tempus Announces $100 Million in Series G Financing".
     
   
Record changed: 2024-04-27

Advertisement

Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x200px

More documents for Tempus Labs Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2024 NYC Game Changers 650x300px




» top